Skip to main content
. 2022 Jul 18;13:927817. doi: 10.3389/fpsyt.2022.927817

TABLE 1.

Comparison of clinical characteristics data and symptom scale assessment among the three groups.

Parameter HC (n = 25) MDD (n = 28) BPD (n = 22) P-value
Age [years, M(P25, P75)] b 31.00(26.50, 38.00) 36.50(30.25, 43.50) 34.00(27.00, 42.00) 0.239
BMI [kg/m2, mean ± SD (range)] a 20.93 ± 2.91
(16.98 – 26.73)
21.61 ± 3.00
(15.20 – 27.69)
21.57 ± 3.60
(14.68 – 27.99)
0.693
HAMD [M(P25, P75)] b 3.00(2.00, 5.50) 25.00(23.00, 26.75)* 20.00(9.25, 27.25)* <0.001
HAMA [M(P25, P75)] b 4.00(2.50, 6.00) 25.50(24.00, 29.00)* 20.00(7.75, 23.25)*# <0.001
PANSS [mean ± SD (range)] b 35.40 ± 3.61
(30.00 – 42.00)
62.04 ± 13.04
(40.00 – 90.00)*
61.55 ± 19.03
(31.00 – 98.00)*
<0.001

aone-way ANOVA; bKruskal Wallis; *P < 0.05 vs. HC group; #< 0.05 vs. MDD group; BMI, body mass index; Values are shown as mean ± SD or M(P25, P75); SD, standard deviation.